You are here
Professor Robert Weintraub
Professor Robert Weintraub is a paediatric cardiologist at the Royal Children's Hospital, Melbourne. He obtained his medical degree from the University of Sydney and trained in paediatrics at the Prince of Wales Children's Hospital in Sydney. After completing a fellowship in paediatric cardiology at the Royal Children's Hospital in Melbourne, Associate Professor Weintraub worked as paediatric cardiologist at Harefield Hospital in the UK, gaining experience in heart transplantation and then as a National Heart Foundation Research Fellow at the University of California Medical Center, San Diego. He returned to Australia in 1992 and since then he has run the paediatric heart failure, transplant and pulmonary hypertension programs at the RCH.
- Cardiologist, Head of Heart Transplant and Pulmonary Hypertension service, Royal Children's Hospital, Melbourne
- Clinical Professor, University of Melbourne
- Australian Cardiovascular Training Fellowship, National Heart Foundation of Australia 1990
- Bristol Laboratories Travel Award, American College of Cardiology 1993
- Bernie O'Callaghan Award, National Heart Foundation of Australia 2000
- Outstanding Research in Pediatric Cardiology, American Heart Association 2008
- Uncle Bob's Travelling Scholarship, Royal Children's Hospital 2014
Professor Robert Weintraub's principal focus is the development of national registries for children with various forms of heart disease. He is a founder and/or chief investigator on the following national registries, which represent major contributions to the care of patients and families with a variety of congenital and childhood diseases:
Professor Weintraub is a member of the Global Burden of Disease 2010 and 2013 study groups (cardiomyopathy and congenital heart disease) and is a co-author on multiple published papers from this study in the Lancet, among othe journals. He has participated in several writing groups to formulate Pediatric Heart Failure and Donor Utilization guidelines for the International Society of Heart & Lung Transplantation .
Professor Weintraub collaborates both nationally and internationally on grant-funded research projects in the areas of pulmonary hypertension in childhood, the molecular genetics of cardiomyopathy, sudden cardiac death in the young, the genetic basis of valvular heart disease, and the Australia and New Zealand Fontan registry.
Key research themes:
- Paediatric cardiomyopathy (national and international registries; whole exome sequencing)
- Paediatric and adult pulmonary hypertension (national and international registries)
- Paediatric heart transplantation (risk factors, outcomes)
- Congenital heart disease (surgical outcomes)
- Global Burden of Disease international study (morbidity, mortality, risk factors, disability-adjusted life years, paediatrics, congenital heart disease, cardiomyopathy)
- Fontan surgery outcomes (Australia and New Zealand registry)
- Echocardiography in congenital heart disease
- International randomised trial of anticoagulation after the Fontan procedure
- The Global Burden of Disease study.
- The National Australian Childhood Cardiomyopathy Study.
- The Congenital Heart Alliance of Australia and New Zealand.
- The Pulmonary Hypertension Society of Australia and New Zealand.
- The Australian and New Zealand Fontan Registry.
- The Tracking Outcomes in Pediatric Pulmonary Hypertension (TOPP) international registry.
- The Sudden Cardiac Death in the Young Study.
- The Melbourne Genomics Health Alliance.
- The Australian Genomics Health Alliance.
- Precision Medicine for Cardiomyopathy (PRIMACY) international registry.
- Sudden Cardiac Death in Hypertrophic Cardiomyopathy international registry.
Shi WY, Moreno-Betancur M, Nugent AW, Cheung M, Colan S, Turner C, Sholler GF, Robertson T, Justo R, Bullock A, King I, Davis AM, Daubeney PEF, Weintraub RG. Long-Term Outcomes of Childhood Left Ventricular Non-Compaction Cardiomyopathy Diagnosed During Childhood: Results from a National Population-Based Study. Circulation 2018; 138(4): 367-376.
Alexander PMA, Nugent AW, Daubeney PEF, Lee KJ, Schuster T, Turner C, Davis AM, Semsarian C, Colan SD, Robertson T, Ramsay J, Justo R, Sholler GF, King I, Weintraub RG. Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results from a National Population-Based Study. Circulation 2018; 138(1): 29-36.
Weintraub RG, Semsarian C, Macdonald P. Dilated Cardiomyopathy. Lancet 2017; 390: 400-414.
Weintraub RG, Alexander PM. Outcomes in Children with Dilated Cardiomyopathy: Quo Vadis. Journal of the American College of Cardiology 2017; 70: 2674-5.
Bagnall, R, Weintraub RG, Duflou J et al. Sudden Cardiac Death in the Young: Results from a Prospective Population-Based Bi-National Registry. New England Journal of Medicine 2016; 37: 2441-52.
Alexander PMA, Daubeney PEF, Nugent AW, Lee KJ, Turner C, Colan SD, Robertson T, Davis AM, Ramsay J, Justo R, Sholler GF, King I, Weintraub RG. Long-Term Outcomes of Dilated Cardiomyopathy Diagnosed During Childhood: Results from a National Population-Based Study of Childhood Cardiomyopathy. Circulation 2013; 128: 2039-46
McCrindle BW, Manlhiot C, Cochrane A, Roberts R, Hughes M, Schetzman B, Weintraub RG, Andrew M, Monagle P. Factors Associated with Thrombotic Complications in the First 2 Years after the Fontan Procedure: A Multicentre Prospective Study. Journal of the American College of Cardiology 2013; 61: 346-53
Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, Gent M, Hughes M, Andrew M, McCrindle BW. A Multicentre Randomized Trial Comparing Heparin/Warfarin Versus Acetylsalicylic Acid as Primary Thromboprophylaxis for Two Years After Fontan Procedure in Children. Journal of the American College of Cardiology 2011; 58: 645-51
Nugent A, Daubeney PED, Chondros P, Carlin JB, Cheung M, Wilkinson JL, Davis AM, Kahler SG, Wilkinson L, Weintraub RG. The Epidemiology of Childhood Cardiomyopathy in Australia. New England Journal of Medicine 2003; 348: 1639-46
Norrish G, Ding T, Fielf E et al. A novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy. JAMA Cardiology
GBD 2016 Mortality Collaborators. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy. 1970-2016: Lancet 2017; 390: 1084-1150.
GBD 2017 mortality investigators. Global, regional, and national age-sex specific mortality and life expectancy, 1950–2017. Lancet 2018; 392; 684-1735.
GBD 2017 population and fertility collaborators. Population and fertility by age and sex for 195 countries and territories 1950–2017. Lancet 2018; 392: 1995-2051.
GBD 2015 Collaborators. Adolescent Health in the Eastern Mediterranean Region. International Journal of Public Health 2018: 63 (Suppl 1): 79-96.8-909.
GBD 2015 Collaborators. Neonatal, Infant, and Under-5 Mortality and Morbidity Burden in the EMR Region. International Journal of Public Health 2018: 63 (Suppl 1): 63-77
GBD collaborators. Child and Adolescent Health 1990 to 2015. JAMA Pediatrics 2017; 171: 573-92.
GBD 2015 Maternal Mortality Collaborators. Maternal Mortality 1990 to 2015. Lancet 2016; 388: 1775-812.
GBD 2015 Child Mortality Collaborators. Global, Regional, National and Selected Subnational Levels of Stillbirths, Neonatal, Infant and Under-5 Mortality During 1980-2015. Lancet 2016; 388: 1725-74.
Kirk R, Dipchand AI, Rosenthal DN et al, Addonizio L, Burch M, Chrisant M, Dubin A, Everitt M, Gajarski R, Mertens L, Miyamoto S, Morales D, Pahl E, Shaddy R, Towbin J, Weintraub R. The International Society of Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure. Journal of Heart and Lung Transplantation 2014: 33(9): 88
2018-2020: Project Grant 1143393, $845,821, Sudden Cardiac Death in the Young. National Health and Medical Research Council.
2017: Heart Foundation Australia Vanguard Grant 101039, $75,000. Clinical and Genetic Basis of Childhood Cardiomyopathies.
2017: Research Grant-in-Aid $50,000, Clinical and Genetic Studies in Children with LVNC Cardiomyopathy. Heart-Kids Australia.
2016-2020: Project Grant 1098931, $1,012,046.80, Genetic Basis of Cardomyopathy. National Health and Medical Research Council.
2016: Research Grant-in-Aid $50,000, Clinical and Genetic Studies in Children and Families with Cardiomyopathy. Heart-Kids Australia.
2014-2016: Project Grant 1065794, $743,660, Improving functional outcomes after Fontan surgery by a cross-sectional study of the outcomes following variation in practice in Australia and New ZealandNational Health and Medical Research Council.
2014-2015: Project Grant 2013-017, $160,000, Clinical and Genetic Basis of Sudden Unexplained Death in Children. Foundation for Children.
2013-2015: Project Grant 1047923, $336,162.45, Detection of Liver and Renal Function Abnormalities in the Australian & New Zealand Population of Fontan Patients. National Health and Medical Research Council.
2013-2015: Project Grant 1051113, $284,818.95, Detection of Cardiac Allograft Rejection by Peripheral Blood Gene Expression: A Novel Concept of Personalized Approach to Transplantation
National Health and Medical Research Council.
2013-2014: Project Grant G 12M 6401, $130,000, Application of Modern Linkage and Genomic Technologies to Identify New Cardiomyopathy Genes. National Heart Foundation of Australia.
2012-2014: Project Grant 1023318, $434,255, Genetic Basis of Valvulatr Heart Disease. National Health and Medical Research Council.
2010-2012: Project Grant 632575, $658,500, Investigation of Sudden Cradiac Death in the Young.
National Health & Medical Research Council
2010-2012: Project Grant 607356, $124,500, The Australia and New Zealand Fontan Registry: a Growing Population of Young Adults with Heart Failure. National Health & Medical Research Council.
2008-2009: Research Grant-in-Aid G 07M 3185, Paediatric Pulmonary Hypertension registry. National Heart Foundation of Australia.
2008-2009: Research Grant-in-Aid G 07M 3180, National Australian Childhood Cardiomyopathy Study. National Heart Foundation of Australia.